Quiz

Welcome to the ESGO 2025 - round I

Put Your Knowledge of Surgical Approaches in Gynaecological Oncology

To The Test

See How You Measure Up!

Let’s start.

Name

Email

1.

Do you think patients should undergo a pre-hysterectomy LEEP/Conisation in order to determine eligibility criteria for less radical surgery (simple hysterectomy)

Yes; because LEEP/Conisation with negative margins offers the opportunity to obtain an objective measurement of the tumor size and depth of stromal invasion

No; because performing a LEEP/Conisation can compromise tumor size assessment if there is residual disease in the hysterectomy specimen

Yes; because protective manoeuvers are not safe enough to prevent tumor dissemination of the vaginal vault

No; because the imaging studies post LEEP/Conisation such as MRI or expert ultrasound cannot accurately interpret the depth of stromal invasion

1 out of 3

2.

Do you think that transvaginal/transrectal ultrasound examination can be used to select patients with cervical cancer for fertility-sparing surgery?

Yes, transvaginal/transrectal ultrasound examination can be used to select patients with cervical cancer for fertility-sparing surgery, but only in cases with no vascularization detected at Color Doppler examination

No, the accuracy of transvaginal/transrectal ultrasound examination in detecting cervical cancers smaller than 2 cm is very poor.

Yes, by using transvaginal/transrectal ultrasound examination it is possible to assess the main parameters necessary for selecting patients for fertility-sparing surgery in cases of cervical cancer.

No, although transvaginal/transrectal ultrasound examination accurately assesses tumor dimensions, it does not provide all parameters required for fertility sparing surgery.

2 out of 3

3.

Based on the results of the SHAPE trial:

Do you think we can now proceed and consider minimally invasive surgery as an acceptable option for selected patients with low-risk cervical cancer?

No, the SHAPE trial showed that minimally invasive surgery is associated with higher recurrence rates.

No, the SHAPE trial focused on comparing simple vs radical hysterectomy and was not designed to evaluate the surgical approach.

Yes, the SHAPE trial demonstrated that minimally invasive surgery is superior to open surgery for these patients.

Yes, since recurrence rates were low among patients undergoing minimally invasive surgery in the SHAPE trial.

3 out of 3

Welcome to the ESGO 2025 - round I

ESGO 2025 Congress

Why Attend

About Us

Follow Us

Subscribe